• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,370.84 761.86
( 1.02%)
Global Indices
Nasdaq
49,714.12 -67.45
(-0.14%)
Dow Jones
7,466.35 44.39
(0.60%)
Hang Seng
62,791.91 -480.20
(-0.76%)
Nikkei 225
10,300.99 35.67
(0.35%)
Forex
USD-INR
95.60 0.47
(0.49%)
EUR-INR
112.29 0.30
(0.26%)
GBP-INR
129.50 0.02
(0.02%)
JPY-INR
0.61 0.00
(0.19%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.394924
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
28.97
107204.87
EPS(TTM)
Face Value()
Div & Yield %
45.81
2
0.98
 

dalmia bharat ltd
Hyundai partners with TVS Motor to co-develop E3W
Apr 20,2026

 Hyundai Motor Company (Hyundai Motor) and TVS Motor Company (TVS Motor) have signed a Joint Development Agreement (JDA) to advance the development and commercialization of innovative Electric Three-Wheeler (E3W) solutions designed specifically to address India's last-mile mobility needs.

The partnership formalized following the successful presentation of the E3W concept at the Bharat Mobility Global Expo 2025, represents a significant step towards bringing tailored mobility solutions to Indian consumers and reinforces both companies' commitment to sustainable urban transportation.

Under the agreement, Hyundai Motor will lead the design of and co-develop the E3W by leveraging its research and development expertise, advanced mobility technologies and human-centric design approach.